Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 2 Results

Intervention Indication Therapeutic Area Year Actions
Avapritinib for unresectable or metastatic gastrointestinal stromal tumours (GIST) who have been treated with at least 3 prior lines of therapy and GIST harbouring the PDGFRA D842V mutation regardless of prior therapy Avapritinib (BLU-285; Ayvakit) Gastrointestinal stromal tumour (GIST) Gastrointestinal Cancer 2019 View  |  Download
Avapritinib for advanced systemic mastocytosis Avapritinib (BLU-285; Ayvakit) Systemic mastocytosis Immunology 2020 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications